physostigmine has been researched along with Cognition Disorders in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (43.59) | 18.7374 |
| 1990's | 4 (10.26) | 18.2507 |
| 2000's | 17 (43.59) | 29.6817 |
| 2010's | 1 (2.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mellios, G | 1 |
| Agrawal, N; Poole, NA | 1 |
| Allen, BD; Balci, F; Brunner, D; Fedolak, TE; Frank, KM; Gibson, JM; Kapustinski, BJ; Ludvig, EA | 1 |
| Barak, S; Weiner, I | 1 |
| Fujita, Y; Hashimoto, K; Horio, M; Ishima, T; Iyo, M; Kohno, M; Kunitachi, S; Shirayama, Y; Tanibuchi, Y | 1 |
| Ilavazhagan, G; Maiti, P; Muthuraju, S; Prasad, D; Sharma, AK; Singh, SB; Solanki, P | 1 |
| Egashira, N; Fujiwara, M; Iwasaki, K; Matsumoto, Y; Mishima, K | 1 |
| Aas, P; Enger, S; Myhrer, T | 1 |
| Arciniegas, DB; Topkoff, JL | 1 |
| Araujo, JA; Milgram, NW; Studzinski, CM | 1 |
| Aasen, I; Kumari, V; Reed, C; Sharma, T | 1 |
| Farchi, N; Hochner, B; Shoham, S; Soreq, H | 1 |
| Flood, P | 1 |
| Bekker, A; Blanck, T; Gingrich, K; Gorny, A; Haile, M; Quartermain, D; Wenning, L | 1 |
| Kircher, T; Leucht, S; Thienel, R; Voss, B | 1 |
| Gershon, S; Goodnick, P | 1 |
| Corwin, J; Jordan, B; Novatt, A; Rotrosen, J; Serby, M | 1 |
| Walton, RG | 1 |
| Eckstein, KL; Vincente-Eckstein, A | 1 |
| Aronson, SM; Berent, S; Giordani, B; Mellow, AM | 1 |
| Bahro, M; Conway, A; Dukoff, R; Friz, J; Lasser, R; Peskind, ER; Sunderland, T; Wilkinson, CW | 1 |
| Falk, WE; Mattes, JA; Newhouse, P; van Dyck, CH | 1 |
| Erb, C; Klein, J; Kopf, S; Löffelholz, K; Schmitt, U; Soreq, H; Troost, J | 1 |
| Braida, D; Sala, M | 1 |
| Davis, JM | 1 |
| Dean, JA; Sutton, EL | 1 |
| Fiore, JP | 1 |
| Gardner, SM; Orkin, FK; Smith, DS; Zakeosian, G | 1 |
| Luauté, JP; Thionville, M | 1 |
| Finlayson, DC; Mogelnicki, SR; Waller, JL | 1 |
| Bidwai, AV; Cornelius, LR; Stanley, TH | 1 |
| Maeda, N; Matsuoka, N; Ohkubo, Y; Yamaguchi, I; Yamazaki, M | 1 |
| Besson, JA; Crawford, JR; Evans, NT; Gemmell, HG; Roeda, D | 1 |
| Haigh, JR; Lines, CR; Poppleton, P; Preston, GC; Traub, M; Ward, C | 1 |
| Riker, WF | 1 |
| Bowman, RE; Levin, ED; Vuchetich, J; Wegert, S | 1 |
| Baker, LH; Corbett, T; Pazdur, R; Phillips, M; Redman, BG | 1 |
| Lips, U; Tryba, M; Zenz, M | 1 |
| Duvoisin, RC; Katz, R | 1 |
6 review(s) available for physostigmine and Cognition Disorders
| Article | Year |
|---|---|
Cholinomimetic agents and neurocognitive impairment following head injury: a systematic review.
Topics: Brain Injuries; Cholinesterase Inhibitors; Cognition Disorders; Cytidine Diphosphate Choline; Humans; Lecithins; Neuropsychological Tests; Nootropic Agents; Physostigmine; Surface-Active Agents; Time Factors | 2008 |
Applications of the P50 evoked response to the evaluation of cognitive impairments after traumatic brain injury.
Topics: Animals; Attention; Brain Injuries; Cholinergic Fibers; Cholinesterase Inhibitors; Cognition Disorders; Evoked Potentials, Auditory; Humans; Memory Disorders; Physostigmine | 2004 |
Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging.
Topics: Acetylcholine; Aging; Animals; Cognition Disorders; Dementia; Disease Models, Animal; Dogs; Humans; Physostigmine; Scopolamine | 2005 |
[Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview].
Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Physostigmine; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2008 |
Chemotherapy of cognitive disorders in geriatric subjects.
Topics: Adrenocorticotropic Hormone; Aged; Aging; Alzheimer Disease; Arecoline; Brain Chemistry; Choline; Cognition Disorders; Cyclandelate; Electroencephalography; Humans; Memory; Methylphenidate; Pentylenetetrazole; Phosphatidylcholines; Physostigmine; Piracetam; Procaine; Vasodilator Agents; Vasopressins | 1984 |
Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies.
Topics: Acetylcholine; Acetylcholinesterase; Activities of Daily Living; Agranulocytosis; Alzheimer Disease; Animals; Behavior, Animal; Biogenic Monoamines; Brain; Cholinesterase Inhibitors; Cognition Disorders; Erythrocytes; Humans; Learning; Memory; Physostigmine; Randomized Controlled Trials as Topic | 2001 |
2 trial(s) available for physostigmine and Cognition Disorders
| Article | Year |
|---|---|
Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation.
Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Phenylcarbamates; Physostigmine; Psychomotor Performance; Rivastigmine; Schizophrenia; Severity of Illness Index; Verbal Behavior | 2006 |
Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Neuropsychological Tests; Physostigmine; Placebos; Treatment Outcome; Vomiting | 2000 |
31 other study(ies) available for physostigmine and Cognition Disorders
| Article | Year |
|---|---|
Donepezil: It is time to replace physostigmine in Anesthesiology.
Topics: Aging; Anesthesia, General; Anesthesiology; Anesthetics; Brain; Cholinergic Neurons; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Humans; Indans; Infusions, Intravenous; Learning; Memory; Physostigmine; Piperidines; Postoperative Period; Quality of Life; Time Factors | 2016 |
Pharmacological manipulations of interval timing using the peak procedure in male C3H mice.
Topics: Animals; Atomoxetine Hydrochloride; Behavior, Animal; Chlordiazepoxide; Cognition; Cognition Disorders; Conditioning, Operant; Dextroamphetamine; Dopamine Agonists; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Methamphetamine; Mice; Mice, Inbred C3H; Nootropic Agents; Physostigmine; Propylamines; Psychophysiology; Reaction Time; Scopolamine; Sodium Chloride; Statistics as Topic; Time Factors; Time Perception | 2008 |
Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Attention; Cholinergic Antagonists; Clozapine; Cognition Disorders; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking Behavior; Glycine; Haloperidol; Inhibition, Psychological; Male; Physostigmine; Rats; Rats, Wistar; Schizophrenia; Scopolamine | 2009 |
Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors.
Topics: Analysis of Variance; Animals; Anisoles; Brain; Cell Membrane; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Hippocampus; Immunohistochemistry; Indans; Male; Mice; Mice, Inbred ICR; Phencyclidine; Physostigmine; Piperidines; Propylamines; Receptors, sigma; Recognition, Psychology; Sigma-1 Receptor; Tritium | 2009 |
Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia.
Topics: Acetylcholine; Acetylcholinesterase; Air Pressure; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Galantamine; Hippocampus; Hypoxia; Male; Maze Learning; Memory; Neurons; Neuroprotective Agents; Physostigmine; Random Allocation; Rats; Rats, Sprague-Dawley | 2009 |
Involvement of reduced acetylcholine release in Delta9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze.
Topics: Acetylcholine; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Cognition Disorders; Dronabinol; Hallucinogens; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Microdialysis; Physostigmine; Rats; Rats, Wistar; Space Perception; Tacrine | 2002 |
Cognitive side effects in rats caused by pharmacological agents used to prevent soman-induced lethality.
Topics: Animals; Cognition Disorders; Drug Therapy, Combination; Exploratory Behavior; Lethal Dose 50; Male; Physostigmine; Procyclidine; Rats; Rats, Wistar; Scopolamine; Soman | 2004 |
Impaired hippocampal plasticity and errors in cognitive performance in mice with maladaptive AChE splice site selection.
Topics: Acetylcholinesterase; Alternative Splicing; Animals; Carbachol; Choice Behavior; Cholinergic Agonists; Cholinesterase Inhibitors; Cognition Disorders; Colforsin; Dose-Response Relationship, Radiation; Electric Stimulation; Excitatory Postsynaptic Potentials; Female; In Vitro Techniques; Long-Term Potentiation; Male; Maze Learning; Mice; Mice, Transgenic; Neuronal Plasticity; Physostigmine; Protein Kinase C; Protein Kinase C beta | 2007 |
A new treatment for hypoxic brain injury?
Topics: Acetylcholine; Acetylcholinesterase; Animals; Behavior, Animal; Brain; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Disease Models, Animal; Exploratory Behavior; Humans; Hypoxia, Brain; Memory; Nootropic Agents; Physostigmine; Research Design; Severity of Illness Index; Time Factors | 2007 |
Physostigmine reverses cognitive dysfunction caused by moderate hypoxia in adult mice.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Behavior, Animal; Brain; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Disease Models, Animal; Exploratory Behavior; Hypoxia, Brain; Male; Memory; Mice; Nootropic Agents; Physostigmine; Severity of Illness Index; Time Factors | 2007 |
Side effects of scopolamine administration.
Topics: Adult; Age Factors; Apraxias; Ataxia; Cognition Disorders; Female; Humans; Illusions; Male; Parasympathetic Nervous System; Physostigmine; Scopolamine | 1984 |
Lecithin and physostigmine for posttraumatic memory and cognitive deficits.
Topics: Adult; Amnesia; Brain Concussion; Cognition Disorders; Female; Humans; Male; Phosphatidylcholines; Physostigmine | 1982 |
[Case report about central effects of physostigmine (author's transl)].
Topics: Adult; Cognition Disorders; Confusion; Herniorrhaphy; Humans; Male; Neuroleptanalgesia; Physostigmine; Psychomotor Agitation | 1980 |
A peptide enhancement strategy in Alzheimer's disease: pilot study with TRH-physostigmine infusions.
Topics: Aged; Alzheimer Disease; Blood Pressure; Cognition Disorders; Drug Therapy, Combination; Female; Humans; Male; Neuropsychological Tests; Peptides; Physostigmine; Pilot Projects; Task Performance and Analysis; Thyrotropin-Releasing Hormone | 1993 |
Physostigmine challenge before and after chronic cholinergic blockade in elderly volunteers.
Topics: Aged; Aging; Brief Psychiatric Rating Scale; Cholinesterase Inhibitors; Cognition Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Female; Glycopyrrolate; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Injections, Intravenous; Male; Muscarinic Antagonists; Neuronal Plasticity; Physostigmine; Pituitary-Adrenal System; Presynaptic Terminals; Receptors, Muscarinic; Scopolamine; Severity of Illness Index; Time Factors; Up-Regulation | 1999 |
Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase.
Topics: Acetylcholine; Acetylcholinesterase; Aging; Anesthetics, Inhalation; Animals; Choline; Cholinesterase Inhibitors; Cognition Disorders; Disease Models, Animal; Exploratory Behavior; Extracellular Space; Genes, Synthetic; Halothane; Hippocampus; Homeostasis; Humans; Inositol Phosphates; Mice; Mice, Transgenic; Microdialysis; Motor Activity; Nerve Tissue Proteins; Physostigmine; Promoter Regions, Genetic; Secretory Rate; Species Specificity; Synaptosomes; Transgenes | 2001 |
Critique of single amine theories: evidence of a cholinergic influence in the major mental illnesses.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bipolar Disorder; Child; Cognition Disorders; Dopamine; Emotions; Humans; Methylphenidate; Middle Aged; Monoamine Oxidase; Neostigmine; Norepinephrine; Parasympathetic Nervous System; Phenothiazines; Physostigmine; Schizophrenia; Sympathetic Nervous System | 1975 |
Cimetidine in the presence of renal impairment.
Topics: Cimetidine; Cognition Disorders; Guanidines; Humans; Kidney Diseases; Physostigmine | 1979 |
Reversal of cimetidine-induced stupor by physostigmine.
Topics: Cimetidine; Cognition Disorders; Consciousness Disorders; Guanidines; Humans; Physostigmine | 1979 |
Prolonged sedation in the elderly after intraoperative atropine administration.
Topics: Age Factors; Aged; Atropine; Bradycardia; Brain; Cognition Disorders; Consciousness Disorders; Female; Humans; Male; Physostigmine; Postoperative Complications | 1979 |
[Anti-cholinergic confusional states connected with chemotherapy of mental diseases: value of eserine sulfate (physostigime)].
Topics: Cognition Disorders; Confusion; Depression; Humans; Mental Disorders; Physostigmine; Psychotropic Drugs; Schizophrenia | 1978 |
Physostigmine reversal of cimetidine--induced mental confusion.
Topics: Cimetidine; Cognition Disorders; Confusion; Humans; Male; Middle Aged; Peptic Ulcer; Physostigmine | 1979 |
Reversal of Innovar-induced postanesthetic somnolence and disorientation with physostigmine.
Topics: Adult; Anesthesia, Intravenous; Anesthetics; Cognition Disorders; Confusion; Consciousness Disorders; Droperidol; Female; Fentanyl; Humans; Male; Middle Aged; Physostigmine | 1976 |
Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks.
Topics: Aging; Animals; Avoidance Learning; Brain; Choline O-Acetyltransferase; Cognition Disorders; Dementia; Discrimination Learning; Disease Models, Animal; Male; Memory Disorders; Methamphetamine; Motor Activity; Physostigmine; Piperazines; Rats; Rats, Inbred F344; Rats, Wistar; Scopolamine; Sulfonamides | 1992 |
PET imaging in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition Disorders; Female; Humans; Male; Middle Aged; Physostigmine; Psychiatric Status Rating Scales; Regional Blood Flow; Tomography, Emission-Computed | 1992 |
Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine.
Topics: Acoustic Stimulation; Adult; Anti-Anxiety Agents; Attention; Cognition Disorders; Dementia; Disease Models, Animal; Female; Flumazenil; Humans; Male; Memory Disorders; Photic Stimulation; Physostigmine; Psychomotor Performance; Pupil; Reaction Time; Scopolamine | 1989 |
Memory impairment in myasthenia gravis.
Topics: Cognition Disorders; Humans; Memory Disorders; Myasthenia Gravis; Physostigmine; Pyridostigmine Bromide | 1989 |
Psychopharmacological investigations of a lead-induced long-term cognitive deficit in monkeys.
Topics: Acetylcholine; Amphetamine; Animals; Behavior, Animal; Cognition Disorders; Dopamine; Haloperidol; Lead Poisoning; Levodopa; Macaca mulatta; Physostigmine; Scopolamine; Sulpiride | 1987 |
Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine model.
Topics: Animals; Antineoplastic Agents; Cognition Disorders; Consciousness Disorders; Drug Evaluation; Drug Evaluation, Preclinical; Gastrointestinal Diseases; Humans; Hydantoins; Mice; Mice, Inbred Strains; Neoplasms; Nitrogen Mustard Compounds; Physostigmine; Speech Disorders | 1987 |
[Unexpected cerebral side effects of ranitidine].
Topics: Aged; Cognition Disorders; Confusion; Female; Humans; Physostigmine; Ranitidine | 1985 |
Reversal of central anticholinergic syndrome in man by physostigmine.
Topics: Aged; Ataxia; Central Nervous System Diseases; Child; Cognition Disorders; Delirium; Female; Hallucinations; Humans; Male; Middle Aged; Neostigmine; Parasympatholytics; Parkinson Disease; Physostigmine; Preanesthetic Medication; Scopolamine; Speech Disorders; Trihexyphenidyl | 1968 |